Suchergebnisse - "Pan, Jingxuan"

PubPharm (15)

1

Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia

enthalten in: Cancer letters | 2020

von Gupta, P. | Zhang, G. | Barbuti, A. | +8

2

Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells

enthalten in: Cancer research | 2018

von Liu, C. | Nie, D. | Li, J. | +6

3

Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant

enthalten in: Cell death & disease | 2018

von Jin, B. | Wang, C. | Shen, Y. | +1

4

Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Jin, Y. | Nie, D. | Li, J. | +6

5

Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia

enthalten in: The Journal of clinical investigation | 2016

von Jin, Y. | Zhou, J. | Xu, F. | +8

6

Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib

enthalten in: Theranostics | 2016

von Jin, Y. | Yao, Y. | Chen, L. | +8

7

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells

enthalten in: Oncotarget | 2014

von Shen, Y. | Ren, X. | Ding, K. | +3

8

SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells

enthalten in: Cancer biology & therapy | 2014

von Bu, Q. | Cui, L. | Li, J. | +4

9

Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib

enthalten in: Journal of medicinal chemistry | 2013

von Ren, X. | Pan, X. | Zhang, Z. | +17

10

The conformational control inhibitor of tyrosine kinases DCC-2036 is effective for imatinib-resistant cells expressing T674I FIP1L1-PDGFRα

enthalten in: PloS one | 2013

von Shen, Y. | Shi, X. | Pan, J.